SEARCH

SEARCH BY CITATION

References

  • 1
    Ashikaga T, Krag DN, Land SR et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 2010; 102: 1118.
  • 2
    Krag DN, Anderson SJ, Julian TB et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010; 11: 92733.
  • 3
    NCCN clinical practice guidelines in oncology, breast cancer. Version 2. BINV-D, 2011 [Cited 16 Sep 2011.] Available from URL: http://www.nccn.com.
  • 4
    Cho J, Han W, Lee JW et al. A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systems. Ann Surg Oncol 2008; 15: 227886.
  • 5
    Wong SL, Edwards MJ, Chao C et al. Predicting the status of the nonsentinel axillary nodes: a multicenter study. Arch Surg 2001; 136: 5638.
  • 6
    Sanjuan A, Escaramis G, Vidal-Sicart S et al. Predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement: evaluation of two scoring systems. Breast J 2010; 16: 13440.
  • 7
    Coufal O, Pavlik T, Fabian P et al. Predicting non-sentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a Czech population? Pathol Oncol Res 2009; 15: 73340.
  • 8
    Unal B, Gur AS, Kayiran O et al. Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system. Int J Clin Pract 2008; 62: 178591.
  • 9
    Viale G, Maiorano E, Pruneri G et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 2005; 241: 31925.
  • 10
    Farshid G, Pradhan M, Kollias J, Gill PG. A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node. Breast 2004; 13: 494501.
  • 11
    Van Zee KJ, Manasseh DM, Bevilacqua JL et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003; 10: 114051.
  • 12
    Pal A, Provenzano E, Duffy SW, Pinder SE, Purushotham AD. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 2008; 95: 3029.
  • 13
    Degnim AC, Reynolds C, Pantvaidya G et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 2005; 190: 54350.
  • 14
    Barranger E, Coutant C, Flahault A, Delpech Y, Darai E, Uzan S. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 2005; 91: 1139.
  • 15
    Hwang RF, Krishnamurthy S, Hunt KK et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 2003; 10: 24854.
  • 16
    Kohrt HE, Olshen RA, Bermas HR et al. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. Bmc Cancer 2008; 8: 66.
  • 17
    Saidi RF, Dudrick PS, Remine SG, Mittal VK. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer. Am Surg 2004; 70: 1015.
  • 18
    Perhavec A, Perme MP, Hocevar M, Besic N, Zgajnar J. Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node. Breast Cancer Res Treat 2010; 119: 35766.
  • 19
    Chagpar AB, Scoggins CR, Martin RN et al. Prediction of sentinel lymph node-only disease in women with invasive breast cancer. Am J Surg 2006; 192: 8827.
  • 20
    Gur AS, Unal B, Ozbek U et al. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study. Eur J Surg Oncol 2010; 36: 305.
  • 21
    Hung WK, Chan CM, Ying M, Chong SF, Mak KL, Yip AW. Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer. Br J Surg 2005; 92: 14947.
  • 22
    Cody HR, Fey J, Akhurst T et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 2001; 8: 139.
  • 23
    Krag DN, Anderson SJ, Julian TB et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007; 8: 8818.
  • 24
    Specht MC, Kattan MW, Gonen M, Fey J, Van Zee KJ. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 2005; 12: 6549.
  • 25
    van la Parra RF, Peer PG, Ernst MF, Bosscha K. Meta-analysis of predictive factors for non-sentinel lymph node metastases in breast cancer patients with a positive SLN. Eur J Surg Oncol 2011; 37: 2909.
  • 26
    Cadili A, Dabbs K, Scolyer RA, Brown PT, Thompson JF. Re-evaluation of a scoring system to predict nonsentinel-node metastasis and prognosis in melanoma patients. J Am Coll Surg 2010; 211: 5225.
  • 27
    Coutant C, Olivier C, Lambaudie E et al. Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol 2009; 27: 28008.
  • 28
    Cserni G. Comparison of different validation studies on the use of the Memorial-Sloan Kettering Cancer Center nomogram predicting nonsentinel node involvement in sentinel node-positive breast cancer patients. Am J Surg 2007; 194: 699700.
  • 29
    Lambert LA, Ayers GD, Hwang RF et al. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 2006; 13: 31020.
  • 30
    van la Parra RF, Ernst MF, Bevilacqua JL et al. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram. Ann Surg Oncol 2009; 16: 112835.
  • 31
    Cserni G, Bianchi S, Vezzosi V et al. Validation of clinical prediction rules for a low probability of nonsentinel and extensive lymph node involvement in breast cancer patients. Am J Surg 2007; 194: 28893.
  • 32
    Houvenaeghel G, Nos C, Giard S et al. A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J Surg Oncol 2009; 35: 6905.
  • 33
    Alran S, De Rycke Y, Fourchotte V et al. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol 2007; 14: 2195201.
  • 34
    Gur AS, Unal B, Johnson R et al. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy. J Am Coll Surg 2009; 208: 22935.